Transplantation of pancreatic islets can provide long-lasting insulin independence for diabetic patients, but the current islet supply is limited. Here we describe a new in vitro system that utilizes adult human pancreatic islet-enriched fractions to generate hormone-producing cells over 3-4 weeks of culture. By labeling proliferating cells with a retrovirus-expressing green fluorescent protein, we show that in this system hormoneproducing cells are generated de novo. These hormone-producing cells aggregate to form islet-like cell clusters. The cell clusters, when tested in vitro, release insulin in response to glucose and other secretagogues. After transplantation into immunodeficient, nondiabetic mice, the islet-like cell clusters survive and release human insulin. We propose that this system will be useful as an experimental tool for investigating mechanisms for generating new islet cells from the postnatal pancreas, and for designing strategies to generate physiologically competent pancreatic islet cells ex vivo.
INTRODUCTION
hormone-producing cells in the regenerating pancreas is presently uncertain. One hypothesis is that during development and in the neonatal period new islet cells arise The mammalian pancreatic islets of Langerhans are composed of four different hormone producing cell types, by direct replication of islet cells, and that in the adult the new islet cells arise from stem and progenitor cells α, β, δ, and PP cells, which secrete glucagon, insulin, somatostatin, and pancreatic polypeptide, respectively.
(3,5). Because sections of regenerating adult pancreas often show islets in close proximity to pancreatic ducts, Diabetes results from a selective immune-mediated loss (type 1), or malfunction and long-term loss (type 2), of it has also been suggested that adult pancreatic stem and progenitor cells might reside within pancreatic ducts insulin-producing β-cells. Transplantation of pancreatic islets has recently been shown to provide insulin inde- (7, 19) . In fact, several groups have reported derivation of insulin-producing cells from mouse and human duct-pendence in patients with type 1 diabetes (22, 38, 39, 44) . The severe shortage of islets is one obstacle preventing enriched pancreatic tissue (6,17,36). However, results from in vivo lineage tracing of islet and duct cells in islet transplantation from becoming a widespread clinical modality. Generation of functional islets ex vivo could mice do not support the ductal origin of islet hormoneproducing cells (20) . Moreover, a recent report questions overcome this obstacle, but such protocols are not presently available.
the existence of resident stem cell pool in adult mouse pancreas (15) . Using quantitative in vivo lineage tracing The adult mammalian pancreas can adaptively increase β-cell mass in response to metabolic challenges and can of insulin-expressing cells, these authors concluded that new β-cells in the adult mouse pancreas arise via repli-at least partially regenerate following injury (4, 12, 30, 48) . This suggests that new hormone-producing cells cation of resident β-cells and not from insulin-negative stem or progenitor cells. A challenge now facing the can be generated after birth. However, the source of new 736 ATOUF ET AL. field is to conclusively establish the cellular origins of amide (Sigma), and 20 ng/ml of bFGF during stage 2 (5-7 days after plating at high density), followed by cul-new hormone-producing cells in the postnatal pancreas, and to uncover the molecular mechanisms responsible turing in the absence of bFGF for the remainder of the experiment (stage 3). for generating these new cells. In vitro systems that utilize human pancreatic tissue to generate new islet cells Immunocytochemistry under controlled culture conditions provide a valuable experimental tool for these studies (5, 6, 16) .
Cells were fixed with 4% paraformaldehyde in PBS for 20 min at room temperature and washed three times In this work we describe an in vitro differentiation system derived from adult human islet-enriched fractions with PBS, 0.1% BSA. Depending on the primary antibody, the cells were either permeablized in 0.3% Triton (IEFs) that can generate new hormone-producing cells. Upon aggregation, these cells self-organize into three-X-100 and blocked in PBS/10% normal goat or donkey serum for 1 h at room temperature, or treated with 100% dimensional islet-like cell clusters (ILCCs). When ILCCs are exposed in vitro to glucose and other insulin release cold methanol on ice for 10 min and blocked with PBS/ 10% normal goat or donkey serum. The primary and sec-agonists, they secrete insulin with kinetics similar to that of normal islets. The ILCCs grafted beneath the kidney ondary antibody reactions were carried out using standard protocols. The following primary antibodies were capsule of immunodeficient nondiabetic mice express islet hormones and secrete human insulin/C-peptide.
used at the following dilutions: insulin mouse mono- (Table 1) . To emphasize the mixed nature of these preparations (islet and extra-islet cell composition), they human nuclear antigen-ANA-mouse monoclonal 1:20 (Chemicon, Inc., Temecula, CA), bromodeoxyuridine, are referred to as islet-enriched fractions (IEFs). For cell culture ( Fig. 1A) , the IEFs were plated on bovine fibro-5-bromo-2′-deoxyuridine (BrdU) rat monoclonal 1:100 (Accurate Chemical and Scientific Corp., Westbury, NY). nectin/concanavalin A (Fn, 2 µg/ml; ConA, 1 µg/ml, both from Sigma) coated tissue culture grade dishes in DMEM For detection of the primary antibodies, Alexa Fluor 488 (green, Molecular Probes, Inc., Eugene, OR) and CY-3 (25 mM glucose) medium with 10% fetal bovine serum (FBS, both from Invitrogen, Carlsbad, CA; stage 1, Fig. (red, Jackson Immunoresearch Laboratories, West Grove, PA) conjugated secondary antibodies were used accord-1A). After 48 h in serum containing medium, 50-80% of IEFs attach to the tissue culture dishes. At this time, ing to methods recommended by the manufacturers. For negative control experiments the primary antibodies were the serum-containing medium was replaced with the serumfree ITSFn (insulin/transferrin/selenium/fibronectin) me-omitted from the reactions. dium (26 mM glucose) (28, 32) containing 20 ng/ml of Retroviral Marking and BrdU Labeling basic fibroblast growth factor (bFGF, R&D Systems, of Proliferating Cells Minneapolis, MN). After 10-12 days fraction "c" cells, and the remaining input clusters (fraction "b") were dis-For the retroviral infections, the IEFs were cultured using standard protocols ( Fig. 1A ). Selected cultures lodged from tissue culture dishes using mild trypsin digestion for 5 min at 37°C (0.05% trypsin/0.53 mM were transduced with the supernatant collected from confluent GFP retrovirus-producing cell line (24) . The EDTA, Invitrogen). Clusters were allowed to settle by gravity to separate them from individual cells. Small ali-producer cells were grown in DMEM with 15% FBS. Eighteen hours prior to collection of the retrovirus su-quots of different cell fractions were removed for determination of intracellular C-peptide. For stages 2 and 3 pernatant, the FBS-containing DMEM medium was replaced with serum-free ITS medium, which is used for (Fig. 1A) , fraction "c" cells were plated at high density (1-2 × 10 5 /cm 2 ) on tissue culture plastic or glass cover-the IEF culture (see above). To increase the number of transduced cells, viral supernatants were added every slips precoated with poly-L-ornithine/laminin (poly-O, 15 µg/ml, Sigma; Lam, 1 µg/ml, Becton Dickinson Lab-other day during the whole period of stage 1. Live cultures were monitored for appearance of green fluores-ware, Bedford, MA) in N2 medium (26 mM glucose) (28,32) containing B27 (Invitrogen), 10 mM nicotin-cence. After fixation, GFP expression was detected by immunocytochemistry with the GFP-specific antibody Genomic DNA Technical manual, Table 1 ) and protein content of an average mammalian cell (ϳ0.1 ng/cell, as described above.
BrdU was dissolved in PBS and added to the cultures value obtained from Lab Ref, J. Roskams and L. Rogders, Editors, Cold Spring Harbor Laboratory Press, 2002, at a final concentration of 10 µM. The cells were labeled with BrdU in a 48-h pulse between days 2 and 4 of p. 196). culture. For BrdU immunocytochemistry the cells were RT-PCR fixed in 4% paraformaldehyde at the end of BrdU pulse, treated with 2 M HCl for 45 min at room temperature, The total cellular RNA was isolated using RNEasy kit (Qiagen, Valencia, CA). To remove traces of DNA, neutralized with 0.1 M sodium borate (pH 8.5) for 15 min, and reacted with primary and secondary antibodies the RNA was treated with DNA-free TM DNase (Ambion, Austin, TX) and reverse transcribed into cDNA using using standard protocols.
AMV reverse transcriptase (Roche Diagnostics Corp.,
Quantification of Retrovirally Marked
Indianapolis, IN) and random hexamers (Invitrogen), ac-C-Peptide-Expressing Cells cording to the manufacturer's instructions. Real-time PCR was carried out using TaqMan appa-Stage 3 cultures immunostained with anti-C-peptideand GFP-specific antibodies were imaged using a Con-ratus (Prism, Applied Biosystems, ABI, Foster City, CA) following the manufacturer's recommendations. 18S ri-focal Laser Scanning Microscope (Zeiss LSM 510). The total cells (DAPI-stained nuclei), C-peptide-and GFP-bosomal RNA was used as an internal control. The following human insulin TaqMan primers were used for expressing cells were counted in optical sections from randomly selected ILCCs. We analyzed 28 individual real-time PCR (44): forward: 5′-CAGAAGAGGCCAT CAAGCAGA-3′; reverse: 5′-ACTAGGTAGAGAGCT ILCCs derived from two independent IEF cultures. The counted optical sections in a given confocal Z stack TCCACCAGGT-3′. The fold change in expression levels was calculated using the formula 2 −(∆∆CT) , where ∆∆CT were spaced 20-30 µm apart, making sure not to count the same cell twice.
is the cycle threshold difference between the time points corrected for 18s rRNA.
C-Peptide and Insulin ELISA Cell Perifusion
To determine total intracellular C-peptide (pmol) and C-peptide concentration (pmol/mg of protein) of input
The ILCCs were harvested using mild trypsin digestion as described above, and insulin secretion was as-IEFs and in vitro-derived cells, the cells were washed two times with PBS and resuspended in 500 µl of buffer sessed in a dynamic cell perifusion system by altering the concentration of extracellular glucose or other ago-containing 50 mM HEPES (pH 8.0)/0.1% Triton X-100/ 0.1% NaN 3 . To minimize protein degradation, one tablet nists. ILCCs (50-60) were placed in a column and equilibrated in 2.8 mM glucose, 125 mM NaCl, 5.7 mM of Complete Mini protease inhibitor cocktail (Roche, Basel, Switzerland) was added to each 10 ml of the KCl, 2.5 mM CaCl 2 , 1.2 mM MgCl 2 , and 10 mM HEPES (pH 7.4) with 0.2% bovine serum albumin. The buffer. The cell suspensions were then sonicated on ice for 30 s using the microprobe of a table-top sonicator flow rate of this solution through the perifusion system was carefully maintained at 1 ml/min, and 3-ml fractions (VWR Scientific, West Chester, PA), and the cell debris was removed by centrifugation. Human C-peptide levels were collected. The clusters were challenged by 16.8 mM glucose, 16.8 mM glucose plus 0.25 mM IBMX, or in the cell lysates was determined using Mercodia ELISA kits (ALPCO, Windham, NH) following the manufactur-0.3 mM tolbutamide in 2.8 mM glucose. Insulin released into the eluate was measured by radioimmunoassay er's instructions, and total C-peptide of the IEF cell mass was calculated (Table 1 ). The results are presented (RIA) using antibody-coated tubes (ICN Pharmaceuticals, Costa Mesa, CA) (11). as the mean of three measurements ± SD. To compare the ILCCs' C-peptide concentration with that of normal Cell Transplantation islet preparations [these were reported as insulin concentrations (6)], we divided the reported insulin values by NOD-SCID mice, from Jackson Laboratories (Bar Harbor, ME), were bred for subsequent studies. The hair 3. This ratio reflects the fact that molecular mass of the mature insulin molecule is approximately three times over the right flank was removed by shaving. Under aseptic conditions, a right flank incision was made to larger then that of the C-peptide. To convert insulin concentration per microgram of DNA as reported by expose the right kidney. The ILCCs were injected in approximately 30 µl of culture medium beneath the re-Bonner-Weir et al. (6) into C-peptide concentration per milligram of protein (this work) we took into account nal capsule using a 27-gauge butterfly needle (9). We made a special effort to maintain approximately the same DNA content of an average mammalian cell (ϳ5 pg/ cell, value obtained from Promega Madison, WI; Wizard total number of grafted cells per mouse. Because the size of ILCCs varied from 80 to 250 µm in different IEF nectin (stage 1), actively proliferating cells emerged from the clusters after several days of culture. It is note-cultures, we correspondingly varied the number of the injected ILCCs from 1500 to 7000 ILCCs per mouse.
worthy that stage 1 IEFs differed in their capacity to give rise to actively proliferating cells (also see below). After ILCC injection, the kidney was returned to its original location, and the incision was closed using a Whereas in some cultures we obtained approximately the same number of cells in fraction "c" as in fraction double closure technique (9).
"a" (Fig. 1A) , in other cultures we achieved up to 10-Blood Sampling fold cell expansion between these two time points. Over-The lateral aspect of the left hind leg was shaved and all, less islet pure IEF preparations appeared to have enprepped aseptically. An 18-guage needle was used to hanced cell proliferating capacity compared to more islet collect blood from the saphenous vein into a heparinized pure IEFs. However, this trend was not observed with container. Samples were collected at baseline. Human all the IEF preparations examined (results not shown). C-peptide concentration was measured in the plasma by
To investigate the phenotype of stage 1 proliferating human-specific C-peptide RIA (Linco Research). For cells, we pulse-labeled them with BrdU, which incorpomeasuring glucose-stimulated C-peptide release, blood rates into the DNA of replicating cells. Immunocytosamples were collected at baseline and 30 min after inchemistry with a BrdU-specific antibody and cell typetraperitoneal injection of 2 g/kg of a sterile glucose soluspecific antibodies allowed us to address the nature of tion (10).
proliferating cells that emerge in IEF cultures. For this analysis, we used antibodies specific for β-cells, such as Graft Retrieval C-peptide and transcription factor Pdx1, a major regula-Mice were anesthetized with isoflurane. The kidney tor of islet development and β-cell-specific gene exprescontaining the human islet grafts was removed and the sion (23) . Of note, in these cultures we observed a sometissue was embedded in OCT for sectioning. Immunowhat diffused pattern of staining with Pdx1 antibody. histochemistry on frozen mouse kidney sections was per-
We commonly observed such pattern in cultures of acformed using standard protocols (9). Human cells were tively proliferating IEFs, which is in contrast with nuidentified using an anti-human nuclear antigen-specific clear Pdx1 immunostaining in stage 3 ILCCs ( Fig. 1F , antibody as described above. see below). We also examined proliferation of non-βcells, such as cells expressing intermediate filament pro-Electron Microscopy tein nestin [expressed by CNS progenitor cells and mes-Input IEFs, IEF-derived cells, and ILCCs were fixed enchymal cells (29) ] and cytokeratin 19 [CK19, expressed in 5.0% glutaraldehyde in Millonig's double-strength by pancreatic ductal epithelia and by putative islet prophosphate buffer at pH 7.3 for 2 h at 20°C (33), washed genitor cells (7,8)]. Our results demonstrated that differin the buffer, postfixed in 1% osmium tetroxide in Milent cell types, including β-cells, undergo active replicalonig's double-strength phosphate buffer for 2 h, and tion during stage 1 (Fig. 1B) . Also found among the washed in the buffer. Following dehydration through an BrdU-positive cells were nestin-and CK19-expressing ethanol series, samples were embedded in epoxy resin cells. In agreement with the other groups, who observed (LX-112) (31) , which was polymerized at 45°C for 24 nestin expression in pancreatic mesenchyme (18, 27, 42) , h and 60°C for an additional 24 h. Ultrathin (40-50 nm) we had found that the majority of nestin-positive cells sections were cut using a Sorvall Porter-Blum MT2-B coexpressed mesenchymal marker, vimentin (7) (results Ultra-microtome with a Delaware Diamond knife, stained not shown). Overall, our results showed that both epithewith 4% uranyl acetate in 50% ethanol and 0.3% lead lial and mesenchymal cells were expanded during stage citrate (46) , and examined with a JEOL JEM-1010 Trans-1. These results were reproduced with at least three inmission Electron Microscope (TEM). Electron microdependent IEF preparations. graphs were taken using Kodak Electron Microscope When fraction "c" cells were replated at high density Film 4489. For each time point, 40-50 different microthey gradually aggregated to form three-dimensional scopic fields were photographed.
ILCCs (fraction "d," see Materials and Methods for details of experimental protocols). We examined pancre-RESULTS atic endocrine phenotype of the ILCCs using immunocy-Phenotypic Characteristics of IEF Cultures tochemistry and real-time RT-PCR ( Fig. 1C-F) . Because we found that the great majority of insulin-positive cells The scheme for culturing IEFs is shown in Figure  1A . When freshly isolated islet clusters (termed here, also coexpressed C-peptide ( Fig. 1D ), we used both insulin and C-peptide antibodies for immunocytochemical islet enriched fractions or IEFs to emphasize the ubiquitous presence of extraislet cells in the islet preparations) analysis. Our results showed that, in addition to insulin, stage 3 ILCCs expressed Pdx1. Similar to its localization were allowed to adhere to the extracellular matrix fibro- in mature islets, Pdx1 was found in the nucleus of insulin-in more detail, as outlined below. These cultures varied in C-peptide content and islet purity (Table 1) . As more expressing cells (Fig. 1F ). Additionally, we found glucagon-and somatostatin-producing cells in a close associa-IEF preparations became available to us, we incorporated additional strategies for their analysis. Thus, not tion with insulin-expressing cells (Fig. 1E ). Although, as will be addressed below, ILCCs are likely to contain a all the IEF preparations underwent all types of analysis. fraction of input hormone-producing cells (fraction "a"), C-Peptide-Expressing Cells Are Generated De Novo our results strongly suggested that stage 3 ILCCs also included a sizable proportion of hormone-producing cells The C-peptide analysis shown in Table 1 suggests that at least some human IEFs display the capacity to generated de novo during the course of the culture.
To estimate the efficiency of this in vitro system, we generate new C-peptide/insulin-producing cells. To address this question further, we used a GFP-expressing examined C-peptide stoichiometry using a human Cpeptide-specific ELISA. Our results showed that the retrovirus to trace the progeny of proliferating cells in the IEF cultures. Because retroviruses infect exclusively amount of accumulated intracellular C peptide varied considerably between different IEF cultures (Table 1 proliferating cells and permanently integrate into the host cell genome, they provide a useful tool for tracing and results not shown). For example with some IEF preparations, we observed reduction in C-peptide at the end the fate of proliferating cells (24) . To obtain a representative sample of IEF cultures with different outcomes, of the culture (donors 2 and 4), while with other IEFs we detected an increase in C-peptide at the end of the we chose the cultures derived from donors 2 and 5 (Table 1). The IEF cultures were repeatedly infected with culture (donors 1, 3, and 5).
The results of quantitative RT/PCR analysis of steady the GFP retrovirus during stage 1 (Fig. 1A) . After completion of the culture, we examined the expression of state proinsulin mRNA during the course of the culture for two IEF preparations (donors 1 and 2, Table 1) are GFP and C-peptide by stage 3 ILCCs using immunocytochemistry. We observed an abundant population of C-shown in Figure 1C . In both cultures the level of proinsulin mRNA was lower in fraction "c" than in fraction peptide-positive/GFP-positive cells within the ILCCs ( Fig. 2A-C) with approximately 62% of the all GFP-"a." While in the donor 1 IEF culture, the proinsulin mRNA had increased at the end of the culture (fraction positive cells also staining for C-peptide and approximately 16% of all cells comprising stage 3 cultures "d") compared to fraction "c," it was further reduced in donor 2 culture. In both cultures we observed a discrep-coexpressing GFP and C-peptide (Fig. 2D) . These results imply that these GFP-positive/C-peptide-positive ancy between the results of RT/PCR and C-peptide analysis for fractions "a" and "c," which was particularly cells were derived from cells that divided during the culture and thus suggest that these C-peptide-positive cells pronounced with donor 2.
During the course of this work we generated cultures were generated de novo. Of note, despite different yields of C-peptide (Table 1) , both IEF cultures contained sim-from 15 individual IEF preparations. For all of these we measured total intracellular C-peptide at different stages ilar percentage of C-peptide-positive/GFP-positive double-labeled cells. of culture (results not shown). We analyzed six cultures Figure 1A . †Expressed as percent of dithizone-positive clusters. Islet Hormones Are Found in Dense-Core Secretory endocrine granules could be identified in end of stage 1 cells (Fig. 3B, C) . Typical at this stage were cells with Granules of ILCCs a distended endoplasmic reticulum (dER) and with numerous Golgi bodies (G), features suggestive of active Electron microscopic (EM) analysis of one IEF culture (donor 3, Table 1 ) at different time points revealed protein synthesis. When stage 3 cells were examined, however, secretory granules characteristic of both βmany cells with typical pancreatic endocrine granules in the input IEF fraction (Fig. 3A) . In contrast, very few cells (Fig. 3E ) and α-cells (Fig. 3F) were easily identi- fied. In some stage 3 cells, αand β-like cell granules To investigate the function of human ILCCs in vivo, we transplanted them under the kidney capsule of five were found in the same cells (Fig. 3D, E) . Figure 3 shows typical microscopic fields for each time point; nondiabetic immunodeficient NOD/SCID mice. Four different ILCC preparations from donors 1, 3, 4, and 5 40-50 microscopic fields for each time pint were examined (see Materials and Methods).
( Table 1) were tested (total duration of culture before transplantation was 24-28 days). The ILCCs from donor ILCCs Produce and Secrete Insulin In Vitro 3 were grafted into two mice, 3(1) and 3(2) (Fig. 4B , and In Vivo C). We found that all transplanted mice secreted human C-peptide. In line with previously observed differences To investigate function of the ILCCs in vitro, we assessed their response to glucose and two other agonists between IEF preparations in vitro, we observed variability in the plasma levels of human C-peptide in mice of insulin secretion, an inhibitor of cyclic-AMP (cAMP) phosphodiesterase, 3-isobutil-1-methylxanthine, IBMX grafted with ILCCs derived from different IEF preparations. Analysis of glucose-stimulated C-peptide release (34), and the sulfonylurea, tolbutamide (45), in a cell perifusion system. Stage 3 ILCCs after 24 days in vitro (Fig. 4C, inset) indicates that grafted cells release Cpeptide in response to glucose several weeks after trans-(donor 6) released insulin in response to glucose, IBMX, and tolbutamide with a pattern similar to normal islets plantation. Animals were sacrificed 6 weeks after grafting and (Fig. 4A, and data not shown) . These findings suggest that the ILCCs have physiological signaling mecha-the kidneys were recovered and sectioned for the immunohistochemical analysis of the transplanted cells. We nisms. Table 1 for specific information on individual IEF cultures). Human C-peptide levels were measured in mouse plasma using human C-peptide-specific ELISA at different times after ILCC transplantation. The inset (C) shows results of glucose-stimulated C-peptide release for one of the transplanted mice (donor 4). For this experiment, blood samples were collected at different times after ILCC transplantation before and 30 min after intraperitoneal injection of 2 g/kg of sterile glucose. used human-specific antinuclear antibody (ANA), which positive cells in the graft. Mouse kidney parenchymal cells surrounding the graft were identified by DAPI reacts with all human cell types and does not react with rodent tissue, to definitively identify cells of human ori-staining and the absence of insulin and ANA immunoreactivity. We have also detected glucagon-and somato-gin (47) . As shown in Figure 5 (A & B) , staining for insulin and ANA within a representative grafted kidney statin-positive cells in the graft (results not shown). Additionally, we found abundant expression of pancreatic demonstrated that the area of insulin immunoreactivity completely overlapped with the area of ANA immunore-ductal marker CK19 (8) in close association with insulin-expressing cells (Fig. 5C ). In most cases insulin and activity, thus confirming the human origin of insulin- CK19 immunoreactivity did not overlap. Of note, the DISCUSSION CK19 mouse monoclonal antibody used in this work (DAKO, see Materials and Methods) is reported not to In this work we describe an in vitro pancreatic culture system that utilizes human adult IEFs to generate new recognized mouse CK19; this specificity implies human origin of the CK19-expressing cells. Interestingly, a siz-insulin-and C-peptide-producing β-like cells. Our results with GFP retrovirus labeling suggest that a propor-able proportion of ILCCs appeared to migrate into the kidney parenchyma (ANA-positive cells, Fig. 5A ). The tion of β-like cells in culture are derived from proliferating cells populations and are thus generated de novo. extent of this migration varied between individual grafts. This type of cellular migration was not observed with
The β-like cells expressed C-peptide and self-assembled into three-dimensional ILCCs. Additionally, the ILCCs freshly isolated human islets transplanted beneath the kidney capsule of NOD/SCID mice (M.F. and A.P., un-expressed glucagon, somatostatin, and the β-cell-specific transcription factor, PDX1. When tested in vitro, the published observations).
ILCCs secreted insulin in response to glucose and other tive analysis of GFP retroviral marking experiments revealed that at least 27% of cells became labeled with the insulin release agonists. The cells comprising the ILCCs contained dense core secretory granules resembling those GFP retrovirus during stage 1 and thus represented new cells generated in vitro ( Fig. 2D ). Of these new cells, of native islet cells. Moreover, after grafting under the kidney capsule of NOD/SCID nondiabetic mice, the approximately 62% expressed C-peptide/insulin at the end of the culture (Fig. 2) , implying that the ILCCs were ILCCs survived and released human C-peptide into the circulation for a period of at least 6 weeks.
comprised of at least 16% of newly generated C-peptide/ insulin-producing cells. Because the efficiency of retro-Our overall culturing strategy and choice of bFGF as mitogen was based on the protocols previously optimized viral labeling is likely to be less than 100% and because cells that divided during stages 2 and 3 (no GFP retrovi-for production of neural cell types from CNS stem and ES cells (28, 35) . Because neural and pancreatic cells rus exposure) would escape detection, the 16% value most likely underrepresents the insulin cell-generating share multiple similarities (26, 40) , success of this protocol with islet cultures may not be particularly surprising. capacity of this system. Interestingly, despite different C-peptide yield in the two IEF preparations marked with In this regard, we and others have shown recently that multiple neural cell types could be derived from in vitro the retrovirus (donors 2 and 5, Table 1) , we detected a similar proportion of GFP-positive/C-peptide-positive cultures of adult mouse pancreas (13, 41) . Moreover, we detected active proliferation of nestin-expressing cells labeled cells in the ILCCs derived from these preparations. and other neural-like cell types in the human IEFs cultures ( Fig. 1B, and results not shown) . These results
The cellular origin of new endocrine-like cells comprising the ILCCs is not clear at this time. These cells highlight the developmental similarities between neural and pancreatic cells and open new possibilities to ad-could be derived from hormone-negative putative adult pancreatic stem cells (5). Alternatively, they could be dress these relationships in defined in vitro systems such as the one described in this work. generated from input β-cells via transient epithelialmesenchymal transition and the reverse, mesenchymal-We found that different IEF preparations varied in their ability to give rise to productive in vitro cultures epithelial transitions (EMT and MET), as has been suggested recently (18) . Still another possibility is that new ( Table 1 ). There could be several reasons for this variability. First, it could result from individual donor-endocrine-like cells are derived via direct islet cell replication by mechanism implicated in generation of new βdependent biological differences determined by factors such as age and state of health of the donor prior to cells in adult mouse pancreas in vivo (15) . The BrdU pulse analysis of different cell types present in the IEF death. Second, the duration of cold ischemia of an organ prior to islet isolation and the islet isolation procedure cultures (Fig. 1B) showed that a portion of β-cells divided during stage 1. It is thus possible that β-like cells itself could impact the quality of IEFs. These parameters of the input material could explain significant variability found in the ILCCs at the end of the culture were derived from these replicating input β-cells. On the other in intracellular C-peptide we observed in different input IEF preparations. In a subgroup of IEF preparations, the hand, in addition to β-cells, other cell types also replicated during stage 1 (Fig. 1B) . We thus cannot rule out outcome of the culture correlated with the degree of islet purity with less pure IEFs, generating more productive that these non-β-cells types might also contribute to generation of new islet-like cells. Elucidating the origin of cultures; however, this trend was not always consistent. At this time we cannot conclusively establish which of new islet-like cells and the mechanism of their generation requires tracing the lineage of different cell types the input IEF parameters plays the principal role in determining the culture outcome, because we studied a rel-during the course of the culture, a task difficult to accomplish in human systems. To address the origin of atively small number of preparations. Given this variability, assessing contribution of various parameters is a new hormone-producing cells in vitro, we are currently taking advantage of cre/loxP reporter transgenic mouse difficult undertaking in cultures of human cadaveric tissue. Rodent-based in vitro pancreatic culture systems system where cre recombinase is placed under control of different pancreatic and nonpancreatic promoters (21) . such as the one recently developed by our group (13) should provide a more standardized model to address
Recently several groups reported ex vivo expansion of hormone-producing cells from cultures of adult hu-these questions.
The C-peptide stoichiometry measurements suggest man islet-enriched fractions (1, 18, 49) . While several of these reported an expansion of the input cell mass, the that hormone-producing cell mass can be expanded in our cultures. This hypothesis is further supported by the expanded cells synthesized relatively low levels of insulin/C-peptide. In contrast, the ILCCs in our report had GFP retroviral marking experiments. While our results indicated that a portion of endocrine cells from the input C-peptide levels approximating those found in normal human islet preparations (6). We found that glucose re-IEFs survived until the end of the culture, the quantita-
